8-K ·Filed Jun 15, 2026
8-K context-dependent: Items 8.01
Actionable Insight • Neutral
This is a routine scheduling notice with no trading implications. Monitor the upcoming proxy statement for any shareholder proposals or governance changes, but no immediate action is warranted.
Final — all horizons settled through T+60d ⚠ clustered
PDSB ▼ -71.27% at T+60d
NEUTRAL call ✗ call lost -71.27% · α vs SPY -72.28% · entry $1.02 → $0.2930
T+1d
-5.88%
call -5.88% · α -5.29%
$0.9600
settled 4mo ago
T+5d
-7.73%
call -7.73% · α -6.34%
$0.9412
settled 3mo ago
T+20d
-26.94%
call -26.94% · α -26.19%
$0.7452
settled 3mo ago
T+60d
-71.27%
call -71.27% · α -72.28%
$0.2930
settled 22d ago
Price Chart
Loading chart...
Executive Summary
PDS Biotechnology Corp filed an 8-K to announce that its 2026 Annual Meeting of Stockholders is scheduled for August 10, 2026, and set a June 25, 2026 deadline for stockholder proposals under Rule 14a-8. This is a routine administrative filing with no material financial or operational impact.
Key Facts
- 2026 Annual Meeting scheduled for August 10, 2026.
- Stockholder proposal deadline set for June 25, 2026 under Rule 14a-8.
- Filing contains no financial data, guidance, or material corporate events.
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-025121 |
| Document: 0001140361-26-025121-index-headers.html | 0001140361-26-025121 |
| Document: 0001140361-26-025121-index.html | 0001140361-26-025121 |
| Document: 0001140361-26-025121.txt | 0001140361-26-025121 |
17 reports for PDSB
70% Hit rate best @ T+20▲ +71.95%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | 8-K | $0.3000 $0.5853 | ▼ −95.10% | ▼ −96.22% | $0.7366 (−145.53%) |
Aug 19, 2026 6w ago | 8-K | $0.2089 $0.2179 | ▲ +4.31% | ▲ +3.19% | $0.7366 (+252.61%) |
Aug 13, 2026 7w ago | 8-K | $0.2332 $0.2089 | ▲ +10.42% | ▲ +8.46% | $0.7366 (−215.87%) |
Aug 11, 2026 7w ago | 8-K | $0.2570 $0.2080 | ▲ +19.07% | ▲ +18.66% | $0.7366 (−186.61%) |
Jul 22, 2026 10w ago | EFFECT | $0.7155 $0.6696 | ▲ +6.42% | ▲ +4.01% | $0.7366 (−2.95%) |
Jun 26, 2026 13w ago | DEFA14A | $0.8991 $0.8461 | ▼ −5.89% | ▼ −7.28% | $0.7366 (−18.07%) |
Jun 15, 2026 15w ago | 8-K | $0.9600 $0.9120 | ▲ +5.00% | ▲ +2.77% | $0.7366 (+23.27%) |
Jun 15, 2026 15w ago | 8-K | $1.02 $0.9412 | ▼ −7.73% | ▼ −6.34% | $0.7366 (−27.78%) |
Jun 2, 2026 17w ago | 8-K | $1.16 $1.03 | ▼ −11.21% | ▼ −8.24% | $0.7366 (−36.50%) |
May 13, 2026 20w ago | Press Release | $1.33 $1.00 | ▼ −24.81% | ▼ −23.65% | $0.7366 (−44.62%) |
Showing 10 of 17
US Market Status
Market Open — Closes in 51m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access